Pharmaceutical
| Mon 03 Aug 2026
Alexandria, Aug. 3 -- U.S. Patent and Trademark Office has received Blueprint Medicines patent application for Solid Forms of a CDK2 Inhibitor. Samipillai Marivel, Kinkema Caitlin N, Kauffman Goss S, Kelly Colin M, Rosner Thorsten S, Hastings Brian T, Poitras Andrew M, Miller David B, Torrey Eric, Maceachern Lauren and Legacy Ch..